The Cooper Companies, Inc. (COO) Average Profit Margin
The current profit margin for The Cooper Companies, Inc. (COO) is N/A as of Sunday, June 14, 2026, shown against its trailing averages.
Average Profit Margin Chart
COO Profit Margin Averages
PROFIT MARGIN CURRENT
N/A
PROFIT MARGIN TTM
9.62%
PROFIT MARGIN 3Y
9.77%
PROFIT MARGIN 5Y
24.94%
PROFIT MARGIN 10Y
19.59%
PROFIT MARGIN 15Y
18.12%
PROFIT MARGIN 20Y
15.39%
About The Cooper Companies, Inc.
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Albert G. White